Publication

Venetoclax with azacitidine or low dose cytarabine as an alternative to intensive chemotherapy in fit adults during the COVID19 pandemic: real world data from the UK National Health Service

Othman, J.
; 
Amer, M.
; 
Amofa, R.
; 
Laura, A.
; 
Austin, M. J.
; 
Bashford, A.
; 
Belsham, E.
; 
Boot, J.
; 
Campbell, V. L.
; 
Coats, T.
... show 10 more
Citations
Altmetric:
Abstract
Authors
Othman, J.
Amer, M.
Amofa, R.
Laura, A.
Austin, M. J.
Bashford, A.
Belsham, E.
Boot, J.
Campbell, V. L.
Coats, T.
Collins, A.
Crawley, C.
Crolla, F.
Cross, J. W.
Dalley, C.
Dang, R.
Dennis, M.
Dhawan, S.
Elliott, Johnathon
Galli, S.
Gallipoli, P.
Hodgson, K.
Jain, M.
Kalkur, P.
Katsomitrou, V.
Khan, A.
Khwaja, A.
Krishnamurthy, P.
Latif, A.
Laurie, J.
Lim, M.
Loizou, E.
Loke, J.
Mannari, D.
Manson, C.
Marshall, S. R.
Mobashwera, B.
Murthy, V.
Ochaya, O.
Orthi, S.
Palanicawandar, R.
Pillai, S.
Radzova, D.
Rye, A.
Saunders, J.
Smith, M.
Taussig, D.
Taylor, T.
Whitmill, R.
Zhao, R.
Freeman, S. D.
Craddock, C.
Dillon, R.
Affiliation
Department of Medical and Molecular Genetics, King's College, London
Description
Date
2021
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Othman J, Amer M, Amofa R, Laura A, Austin MJ, Bashford A, et al. Venetoclax with Azacitidine or Low Dose Cytarabine As an Alternative to Intensive Chemotherapy in Fit Adults during the COVID19 Pandemic: Real World Data from the UK National Health Service. Blood. 2021 Nov;138. PubMed PMID: WOS:000736413901053.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625643
Embedded videos